Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19

Full text
Show less -
Baptista, Abrahao Fontes [1, 2, 3, 4] ; Baltar, Adriana [2, 5] ; Okano, Alexandre Hideki [1, 6, 2, 3] ; Moreira, Alexandre [7] ; Campos, Ana Carolina Pinheiro [8] ; Fernandes, Ana Mercia [9] ; Brunoni, Andre Russowsky [10, 11] ; Badran, Bashar W. [12] ; Tanaka, Clarice [2, 13] ; de Andrade, Daniel Ciampi [2, 9] ; da Silva Machado, Daniel Gomes [14] ; Morya, Edgard [15] ; Trujillo, Eduardo [1, 2] ; Swami, Jaiti K. [16] ; Camprodon, Joan A. [17, 18] ; Monte-Silva, Katia [2, 19] ; Sa, Katia Nunes [20, 2, 21] ; Nunes, Isadora ; Goulardins, Juliana Barbosa [7, 2, 4, 22] ; Bikson, Marom [16] ; Sudbrack-Oliveira, Pedro [23] ; de Carvalho, Priscila [13] ; Duarte-Moreira, Rafael Jardim [1, 2] ; Pagano, Rosana Lima [8] ; Shinjo, Samuel Katsuyuki [24] ; Zana, Yossi [1]
Total Authors: 26
Show less -
[1] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo - Brazil
[2] NAPeN Network Rede Nucleos Assistencia & Pesquisa, Sao Bernardo Do Campo - Brazil
[3] Univ Estadual Campinas, Brazilian Inst Neurosci & Neurotechnol, Ctr Pesquisa Invest & Difusao, Fundacao Amparo Pesquisa Estado Sao Paulo BRAINN, Campinas - Brazil
[4] Univ Sao Paulo, Lab Med Invest 54 LIM 54, Sao Paulo - Brazil
[5] Specialized Neuromodulat Ctr Neuromod, Recife, PE - Brazil
[6] Univ Estadual Londrina, Grad Program Phys Educ, Londrina, Parana - Brazil
[7] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo - Brazil
[8] Hosp Sirio Libanes, Lab Neurosci, Sao Paulo - Brazil
[9] Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Ctr Dor, LIM62, Sao Paulo - Brazil
[10] Inst Nacl Biomarcadores Neuropsiquiatria, Lab Neurociencias LIM 27, Serv Interdisciplinar Neuromodulacao, Sao Paulo - Brazil
[11] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Psiquiatria, Sao Paulo - Brazil
[12] Med Univ South Carolina, Dept Psychiat, Charleston, SC 29425 - USA
[13] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Cent, Sao Paulo - Brazil
[14] Univ Fed Rio Grande do Norte, Grad Program Collect Hlth, Natal, RN - Brazil
[15] Santos Dumont Inst, Edmond & Lily Safra Int Neurosci Inst, Macaiba - Brazil
[16] CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10031 - USA
[17] Harvard Med Sch, Boston, MA 02115 - USA
[18] Massachusetts Gen Hosp, Lab Neuropsychiat & Neuromodulat, Boston, MA 02114 - USA
[19] Univ Fed Pernambuco, Appl Neurosci Lab, Recife, PE - Brazil
[20] Escola Bahiana Med & Saude Publ, Salvador, BA - Brazil
[21] Pontificia Univ Catolica Minas Gerais, Dept Physiotherapy, Betim - Brazil
[22] Univ Cruzeiro Sul UNICSUL, Sao Paulo - Brazil
[23] Univ Sao Paulo, Fac Med FMUSP, Sao Paulo - Brazil
[24] Univ Sao Paulo, Fac Med FMUSP, Div Rheumatol, Sao Paulo - Brazil
Total Affiliations: 24
Document type: Review article
Source: FRONTIERS IN NEUROLOGY; v. 11, NOV 25 2020.
Web of Science Citations: 0

Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be useful in the treatment of the disorders associated with COVID-19. Objective: To describe the rationale and empirical basis of the use of non-invasive neuromodulation in the management of patients with COVID-10 and related disorders. Methods: We summarize COVID-19 pathophysiology with emphasis of direct neuroinvasiveness, neuroimmune response and inflammation, autonomic balance and neurological, musculoskeletal and neuropsychiatric sequela. This supports the development of a framework for advancing applications of non-invasive neuromodulation in the management COVID-19 and related disorders. Results: Non-invasive neuromodulation may manage disorders associated with COVID-19 through four pathways: (1) Direct infection mitigation through the stimulation of regions involved in the regulation of systemic anti-inflammatory responses and/or autonomic responses and prevention of neuroinflammation and recovery of respiration; (2) Amelioration of COVID-19 symptoms of musculoskeletal pain and systemic fatigue; (3) Augmenting cognitive and physical rehabilitation following critical illness; and (4) Treating outbreak-related mental distress including neurological and psychiatric disorders exacerbated by surrounding psychosocial stressors related to COVID-19. The selection of the appropriate techniques will depend on the identified target treatment pathway. Conclusion: COVID-19 infection results in a myriad of acute and chronic symptoms, both directly associated with respiratory distress (e.g., rehabilitation) or of yet-to-be-determined etiology (e.g., fatigue). Non-invasive neuromodulation is a toolbox of techniques that based on targeted pathways and empirical evidence (largely in non-COVID-19 patients) can be investigated in the management of patients with COVID-19. (AU)

FAPESP's process: 19/10760-9 - Circadian variability of motor cortex excitability in patients with Mesial Temporal Lobe Epilepsy: a Transcranial Magnetic Stimulation (TMS) study
Grantee:Pedro Sudbrack Oliveira
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 18/18695-9 - Deep brain stimulation and Parkinsons Disease: neuroinflammation control as therapeutic target
Grantee:Ana Carolina Pinheiro Campos
Support type: Scholarships in Brazil - Doctorate (Direct)